Nerivio is indicated for acute and/or preventive treatment of migraine with or without aura in patients
12 years of age or older. It is a prescription use, self administered device for use in the home environment at the onset of migraine headache or aura for acute treatment, or every other day for preventive treatment.


Nerivio should not be used by people with uncontrolled epilepsy, an active implantable medical device, such as a pacemaker, hearing aid implant, or any implanted electronic device. Such use could cause electric shock, electrical interference or serious injuries or medical conditions.


Nerivio has not been evaluated in people with congestive heart failure (CHF), severe cardiac or cerebrovascular disease, for pregnancy, or those under
the age of 12. Nerivio should only be applied on the upper arm over dry, healthy skin with normal physical sensation and without any metallic implants or in proximity to cancerous lesions. For full user instructions and safety information, please see the Nerivio User Manual.